Tuberculosis in Newborns: The Lessons of the "Lübeck Disaster" (1929-1933)
Gregory J Fox1,2, Marianna Orlova1,3,4, Erwin Schurr1,3,4
1McGill International TB Centre, McGill University, Montreal, Quebec, Canada.
Insights
The Lübeck disaster showed that while most infants survived tuberculosis infection from contaminated vaccines, dose and individual susceptibility significantly impacted outcomes. This highlights human resistance and the critical role of dosage in disease severity.
Area of Science:
- Infectious Disease Epidemiology
- Immunology
- Public Health
Background:
- The Lübeck disaster involved 251 neonates accidentally given Bacille Calmette-Guérin (BCG) antituberculosis (TB) vaccine contaminated with Mycobacterium tuberculosis.
- This event led to 173 infants developing TB, with 72 fatalities, prompting investigation into the cause.
Observation:
- Dr. A. Moegling concluded the BCG vaccine was contaminated with virulent M. tuberculosis, not that BCG reverted to virulence.
- Analysis revealed high mortality (29%) but also significant survival, indicating innate human resistance to TB.
- Variable contamination levels demonstrated that higher doses of M. tuberculosis led to increased susceptibility.
Findings:
- The majority of neonates, despite high mortality, overcame TB, underscoring innate human resistance to the bacillus.
- Innate resistance to TB varied significantly with the dose of M. tuberculosis, with higher doses causing greater susceptibility.
- Infants who died after low-dose inoculation showed faster disease progression, suggesting they were inherently more susceptible.
Implications:
- The study emphasizes the critical role of M. tuberculosis dosage in determining disease severity and outcome.
- Findings suggest that individuals developing severe TB after low exposure may possess heightened genetic susceptibility.
- Lessons learned inform current research into genetic factors influencing susceptibility to tuberculosis.
Abstract:
In an accident later known as the Lübeck disaster, 251 neonates were orally given three doses of the new Bacille Calmette-Guérin (BCG) antituberculosis (TB) vaccine contaminated with Mycobacterium tuberculosis. A total of 173 infants developed clinical or radiological signs of TB but survived the infection, while 72 died from TB. While some blamed the accident on BCG itself by postulating reversion to full virulence, such a possibility was conclusively disproven. Rather, by combining clinical, microbiological, and epidemiological data, the chief public health investigator Dr. A. Moegling concluded that the BCG vaccine had been contaminated with variable amounts of fully virulent M. tuberculosis. Here, we summarize the conclusions drawn by Moegling and point out three lessons that can be learned. First, while mortality was high (approximately 29%), the majority of neonates inoculated with M. tuberculosis eventually overcame TB disease. This shows the high constitutional resistance of humans to the bacillus. Second, four semiquantitative levels of contamination were deduced by Moegling from the available data. While at low levels of M. tuberculosis there was a large spread of clinical phenotypes reflecting a good degree of innate resistance to TB, at the highest dose, the majority of neonates were highly susceptible to TB. This shows the dominating role of dose for innate resistance to TB. Third, two infants inoculated with the lowest dose nevertheless died of TB, and their median time from inoculation to death was substantially shorter than for those who died after inoculation with higher doses. This suggests that infants who developed disease after low dose inoculation are those who are most susceptible to the disease. We discuss some implications of these lessons for current study of genetic susceptibility to TB.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Development of the Oral Microbiota


